, ,

Olaparib 150 mg Tablet for BRCA-mutated cancer treatment

0.00$

+ Free Shipping

Olaparib 150 mg Tablet (Olanib) is a targeted cancer therapy belonging to the PARP inhibitor class. It is used in the treatment of BRCA-mutated ovarian, breast, prostate, and pancreatic cancers by preventing cancer cells from repairing damaged DNA. Prescription use only.

Field Details
Brand Name Olanib
Generic Name Olaparib
Strength 150 mg
Pack Size 120 Tablets
Dosage Form Tablet (Oral)
Manufacturer Everest Pharmaceuticals Ltd.
Made in Bangladesh
Reference Brand Lynparza
Drug Class PARP Inhibitor
Primary Category Oncology Medicines
Secondary Category Ovarian Cancer Treatment
Therapeutic Category Targeted Cancer Therapy
Indication Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer (BRCA-mutated)
Guaranteed Safe Checkout

What is Olaparib 150 mg Tablet?

Olaparib 150 mg Tablet is an oral targeted anti-cancer medication used to treat certain types of solid tumors associated with inherited or acquired BRCA gene mutations. It belongs to a class of medicines known as PARP (Poly ADP-Ribose Polymerase) inhibitors, which help destroy cancer cells by preventing them from repairing damaged DNA.

Olanib is a generic formulation of olaparib and is considered therapeutically equivalent to the reference brand Lynparza®.

Uses of Olaparib 150 mg Tablet

Olaparib is prescribed for adult patients with specific BRCA-mutated cancers, including:

Ovarian Cancer

  • Advanced ovarian cancer with BRCA mutations.
  • Maintenance treatment following a complete or partial response to platinum-based chemotherapy.
  • Certain cases of recurrent ovarian, fallopian tube, or primary peritoneal cancer.

Breast Cancer

  • HER2-negative metastatic breast cancer with germline BRCA mutations.
  • High-risk early-stage breast cancer in eligible patients, as determined by the treating oncologist.

Prostate Cancer

  • Metastatic castration-resistant prostate cancer (mCRPC) associated with BRCA mutations or other eligible homologous recombination repair (HRR) gene alterations.

Pancreatic Cancer

  • Maintenance treatment for metastatic pancreatic cancer with germline BRCA mutations after disease stabilization with platinum-based chemotherapy.

How Olaparib Works

Olaparib inhibits the activity of PARP enzymes, which play an essential role in repairing damaged DNA within cells.

Mechanism of Action

  • Blocks PARP-mediated DNA repair pathways.
  • Causes accumulation of DNA damage in cancer cells.
  • Exploits defects in BRCA-related DNA repair mechanisms.
  • Leads to selective destruction of cancer cells while limiting damage to normal cells.

Dosage and Administration

The dosage and duration of treatment should always be determined by a qualified oncologist based on the patient’s condition and response to therapy.

Administration Guidelines

  • Take exactly as prescribed by your doctor.
  • Can be taken with or without food.
  • Swallow tablets whole with water.
  • Do not crush, chew, split, or dissolve the tablets.
  • Take doses at the same time each day.
  • Do not alter the dose or discontinue treatment without medical advice.
  • If you miss a dose, take the next scheduled dose as instructed by your healthcare provider.

Possible Side Effects

Side effects vary depending on individual response, dosage, and duration of treatment.

Common Side Effects

  • Nausea
  • Fatigue or weakness
  • Anemia (low red blood cell count)
  • Loss of appetite
  • Headache
  • Dizziness

Less Common Side Effects

  • Vomiting
  • Diarrhea
  • Low white blood cell count (leukopenia)
  • Low platelet count (thrombocytopenia)
  • Changes in kidney function tests
  • Altered taste sensation

Serious Side Effects

Seek immediate medical attention if you experience:

  • Persistent fever or signs of infection
  • Shortness of breath
  • Severe fatigue
  • Unusual bruising or bleeding
  • Chest pain
  • Symptoms suggestive of blood disorders

Warnings and Precautions

Olaparib should only be used under the supervision of a specialist experienced in cancer treatment.

Important Safety Information

  • Prescription-only oncology medicine.
  • BRCA mutation testing may be required before treatment initiation.
  • Regular blood count monitoring is essential.
  • Inform your doctor about all medications and supplements you are taking.
  • Avoid use during pregnancy due to the risk of fetal harm.
  • Breastfeeding is not recommended during treatment and for the period advised by your physician after the final dose.
  • Effective contraception should be used by patients of reproductive potential during treatment.

Drug Interactions

Olaparib may interact with certain medicines, including:

  • Strong CYP3A inhibitors (such as certain antifungal medications and antibiotics).
  • Strong CYP3A inducers.
  • Herbal supplements containing St. John’s Wort.
  • Certain anticonvulsants.

Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you use.

Storage Instructions

Proper Storage

  • Store below 30°C.
  • Protect from moisture and direct light.
  • Keep in the original packaging.
  • Keep out of reach of children and pets.

Frequently Asked Questions (FAQs)

What is Olaparib 150 mg Tablet used for?

Olaparib is used to treat BRCA-mutated ovarian, breast, prostate, and pancreatic cancers. It may also be used as maintenance therapy after successful chemotherapy in eligible patients.

Is Olaparib a chemotherapy drug?

No. Olaparib is a targeted therapy known as a PARP inhibitor. It works differently from traditional chemotherapy by specifically targeting cancer cells with defective DNA repair mechanisms.

Is BRCA testing required before taking Olaparib?

Yes. Genetic testing for BRCA mutations is generally necessary to determine whether Olaparib is an appropriate treatment option.

Can Olaparib be taken long term?

Yes. Many patients take Olaparib for extended periods under close supervision, provided the treatment remains effective and side effects are manageable.

How should I take Olaparib 150 mg Tablet?

Take it exactly as prescribed by your oncologist. Swallow the tablet whole, with or without food, and avoid changing the dose without medical advice.

What should I do if I miss a dose?

If you miss a dose, skip it and take your next dose at the scheduled time. Do not take an extra dose to make up for the missed one.

Can Olaparib cause hair loss?

Hair loss is not among the most common side effects of Olaparib, although some patients may notice hair thinning during treatment.

Can I take Olaparib during pregnancy?

No. Olaparib may harm an unborn baby. Inform your doctor immediately if you are pregnant or planning to become pregnant.

Can men taking Olaparib father a child?

Men receiving Olaparib should discuss contraception recommendations with their healthcare provider, as precautions may be necessary during treatment and for a specified period afterward.

Does Olaparib cure cancer?

Olaparib is designed to control cancer progression, prolong remission, and improve outcomes in eligible patients. Whether it can eliminate cancer completely depends on the cancer type, stage, and individual response to treatment.

Disclaimer: This information is intended for educational purposes only and should not replace professional medical advice. Olaparib should only be used under the guidance of a qualified oncologist.

Product Categories

  • Oncology Medicines
  • Targeted Cancer Therapy
  • PARP Inhibitors
  • Ovarian Cancer Treatment
  • Breast Cancer Treatment
  • Prostate Cancer Treatment
  • Pancreatic Cancer Treatment
Let's chat